Metabiota
AcquiredQuantifying epidemic risk for a more resilient world
San Francisco, United States · $38.4M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Business Model
- B2B
- Website
- metabiota.com
- Total Funding
- $38.4M
- Last Round
- $7.4M Series BFeb 2017
- Rounds
- 3
About
Founded in 2008 by virologist Nathan Wolfe, Metabiota built the Global Epidemic Monitoring and Modeling platform quantifying epidemic risk for governments, insurers, and enterprises. In 2018, Metabiota launched PathogenRX, an epidemic risk insurance product developed with Marsh and Munich Re. The company gained prominence during COVID-19 for early modeling of global spread.
Summary
Metabiota is a Healthcare company based in San Francisco, United States. It has raised $38.4M in total across 3 rounds, most recently a $7.4M Series B round in Feb 2017.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2022
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe